Increased Th1 and Th2 immune reactivity with relative Th2 dominance in patients with acute exacerbation of schizophrenia

Croatian Medical Journal

Volumn 46, Issue 2, 2005, Pages 268-274

  Avguštin, Bojana ^a   Wraber, Branka ^b   Tavčar, Rok ^a  

^a UNIVERSITY PSYCHIATRIC HOSPITAL   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CHLORPROMAZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOZAPINE; GAMMA INTERFERON; HYPNOTIC AGENT; INTERLEUKIN 4; NEUROLEPTIC AGENT; PHORBOL 13 ACETATE 12 MYRISTATE; INTERLEUKIN 18;

ACUTE DISEASE; ADULT; ARTICLE; CELL STIMULATION; CELLULAR IMMUNITY; CYTOKINE RELEASE; DISEASE EXACERBATION; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELPER CELL; HEMISPHERIC DOMINANCE; HIGH RISK PATIENT; HUMAN; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; RISK FACTOR; SCHIZOPHRENIA; SYMPTOMATOLOGY; TH1 CELL; TH2 CELL; BLOOD; CASE CONTROL STUDY; DISEASE COURSE; IMMUNOLOGY; IN VITRO STUDY; PATHOLOGY; SECRETION;

ACUTE DISEASE; ADULT; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; INTERLEUKIN-18; INTERLEUKIN-4; MALE; SCHIZOPHRENIA; TH1 CELLS; TH2 CELLS;

EID: 18844454972     PISSN: 03539504     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Moises HW, Schindler L, Leroux M, Kirchner H. Decreased production of interferon alpha and interferon gamma in leucocyte cultures of schizophrenic patients. Acta Psychiatr Scand. 1985;72:45-50.
2. Smith RS, Maes M. The macrophage-T-lymphocyte theory of schizophrenia: additional evidence. Med Hypotheses. 1995;45:135-41.
3. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol. 1986;136: 2348-57.
4. Hinze-Selch D, Pollmacher T. In vitro cytokine secretion in individuals with schizophrenia: results, confounding factors, and implications for further research. Brain Behav Immun. 2001;15:282-318.
5. Ganguli R, Yang Z, Shurin G, Chengappa KN, Brar JS, Gubbi AV, et al. Serum interleukin-6 concentration in schizophrenia: elevation associated with duration of illness. Psychiatry Res. 1994;51:1-10.
6. Maes M, Bocchio Chiavetto L, Bignotti S, Battisa Tura GJ, Pioli R, Boin F, et al. Increased serum interleukin-8 and interleukin-10 in schizophrenic patients resistant to treatment with neuroleptics and the stimulatory effects of clozapine on serum leukemia inhibitory factor receptor. Schizophr Res. 2002;54;281-91.
7. Ganguli R, Brar JS, Chengappa KR, DeLeo M, Yang ZW, Shurin G, et al. Mitogen-stimulated interleukin-2 production in never-medicated, first-episode schizophrenic patients. The influence of age at onset and negative symptoms. Arch Gen Psychiatry. 1995;52;668-72.
8. Bessler H, Levental Z, Karp L, Modai I, Djaldetti M, Weizman A. Cytokine production in drug-free and neuroleptic-treated schizophrenic patients. Biol Psychiatry. 1995;38:297-302.
9. Muller N. Immunological and infectious aspects of schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2004;254:1-3.
10. Rothermundt M, Arolt V, Weitzsch C, Eckhoff D, Kirchner H. Production of cytokines in acute schizophrenic psychosis. Biol Psychiatry. 1996;40:1294-7.
11. Wilke I, Arolt V, Rothermundt M, Weitzsch C, Hornberg M, Kirchner H. Investigations of cytokine production in whole blood cultures of paranoid and residual schizophrenic patients. Eur Arch Psychiatry Clin Neurosci. 1996;246:279-84.
12. Maes M, Bosmans E, Calabrese J, Smith R, Meltzer HY. Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers. J Psychiatr Res. 1995;29:141-52.
13. Katila H, Cantell K, Hirvonen S, Rimon R. Production of interferon-alpha and gamma by leukocytes from patients with schizophrenia. Schizophr Res. 1989;2:361-5.
14. Arolt V, Weitzsch C, Wilke I, Nolte A, Pinnow M, Rothermundt M, et al. Production of interferon-gamma in families with multiple occurrence of schizophrenia. Psychiatry Res. 1997;66:145-52.
15. Rothermundt M, Arolt V, Weitzsch C, Eckhoff D, Kirchner H. Production of cytokines in acute schizophrenic psychosis. Biol Psychiatry. 1996;40:1294-7.
16. Rothermundt M, Arolt V, Leadbeater J, Peters M, Rudolf S, Kirchner H. Cytokine production in unmedicated and treated schizophrenic patients. Neuroreport. 2000;11: 3385-8.
17. Cazzullo CL, Sacchetti E, Galluzzo A, Panariello A, Colombo F, Zagliani A, et al. Cytokine profiles in drug-naive schizophrenic patients. Schizophr Res. 2001;47: 293-8.
18. Hornberg M, Arolt V, Wilke I, Kruse A, Kirchner H. Production of interferons and lymphokines in leukocyte cultures of patients with schizophrenia. Schizophr Res. 1995;15:237-42.
19. Kocjan T, Wraber B, Kocijancic A, Hojker S. Methimazole upregulates T-cell-derived cytokines without improving the existing Th1/Th2 imbalance in Graves' disease. J Endocrinol Invest. 2004;27:302-7.
20. Sega S, Wraber B, Mesec A, Horvat A, Ihan A. IFN-beta1a and IFN-beta1b have different patterns of influence on cytokines. Clin Neurol Neurosurg. 2004;106: 255-8.
21. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington (DC): American Psychiatric Press; 1994.
22. Shiloh R, Nutt D, Weizman A, editors. Essentials in clinical psychiatric pharmacotherapy. London: Martin Dunitz Ltd; 2001.
23. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261-76.
24. Kallmann BA, Huther M, Tubes M, Feldkamp J, Bertrams J, Gries FA, et al. Systemic bias of cytokine production toward cell-mediated immune regulation in IDDM and toward humoral immunity in Graves' disease. Diabetes. 1997;46:237-43.
25. Kim YK, Myint AM, Lee BH, Han CS, Lee HJ, Kim DJ, et al. Th1, Th2 and Th3 cytokine alteration in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2004;28:1129-34.
26. Licinio J, Seibyl JP, Altemus M, Charney DS, Krystal JH. Elevated CSF levels of interleukin-2 in neuroleptic-free schizophrenic patients. Am J Psychiatry. 1993;150: 1408-10.
27. Lin A, Kenis G, Bignotti S, Tura GJ, De Jong R, Bosmans E, et al. The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6. Schizophr Res. 1998;32:9-15.
28. Mittleman BB, Castellanos FX, Jacobsen LK, Rapoport JL, Swedo SE, Shearer GM. Cerebrospinal fluid cytokines in pediatric neuropsychiatric disease. J Immunol. 1997;159:2994-9.
29. Murray RM, O'Callaghan E, Castle DJ, Lewis SW. A neurodevelopmental approach to the classification of schizophrenia. Schizophr Bull. 1992;18:319-32.
30. Murray RM, Jones P, O'Callaghan E, Takei N, Sham P. Genes, viruses and neurodevelopmental schizophrenia. J Psychiatr Res. 1992;26:225-35.
31. Cannon TD, Rosso IM, Hollister JM, Bearden CE, Sanchez LE, Hadley T. A prospective cohort study of genetic and perinatal influences in the etiology of schizophrenia. Schizophr Bull. 2000;26:351-66.
32. Koponen H, Rantakallio P, Veijola J, Jones P, Jokelainen J, Isohanni M. Childhood central nervous system infections and risk for schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2004;254:9-13.
33. Altamura AC, Boin F, Maes M. HPA axis and cytokines dysregulation in schizophrenia: potential implications for the antipsychotic treatment. Eur Neuropsychopharmacol. 1999;10:1-4.
34. Cotter D, Pariante CM. Stress and the progression of the developmental hypothesis of schizophrenia. Br J Psychiatry. 2002;181:363-5.
35. Thomas HV, Dalman C, David AS, Gentz J, Lewis G, Allebeck P. Obstetric complications and risk of schizophrenia. Effect of gender, age at diagnosis and maternal history of psychosis. Br J Psychiatry. 2001;179:409-14.
36. Aitchison KJ, Meehan K, Murry R. Why focus on the first episode? In Aitchison KJ, Meehan K, Murray RM, editors. First episode psychosis. London: Martin Dunitz Ltd; 1999. p. 1-9.
37. Haack M, Hinze-Seich D, Fenzel T, Kraus T, Kuhn M, Schuld A, et al. Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis. J Psychiatr Res. 1999;33:407-18.
38. Paganelli R, Scala E, Quinti I, Ansotegui IJ. Humoral immunity in aging. Aging (Milano). 1994;6:143-50.
39. Pollmacher T, Haack M, Schuld A, Kraus T, Hinze-Selch D. Effects of antipsychotic drugs on cytokine networks. J Psychiatr Res. 2000;34:369-82.